Antiplatelet agents
Antiplatelet drugs such as aspirin counter platelet aggregation by targeting COX enzymes and P2Y12 ADP receptors. Others, like abciximab, eptifibatide, and tirofiban, inhibit GP IIb/IIIa receptors, preventing the binding of fibrinogen to platelets. Additionally, phosphodiesterase inhibitors like dipyridamole and cilostazol increase cAMP and ...